tirzepatide journal club In the SURMOUNT-1 trial (published in NEJM in July 2022), adults with #obesity treated with weekly tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor Tirzepatide - 6 Month Renewal

Nrf2 can then translocate to the nucleus and bind to the antioxidant response element (ARE) located in the promoters of genes coding for antioxidant/detoxifying enzymes and scavengers

Data on GLP-1 analogs for psoriasis Researchers have known for some time about an association between psoriasis and diabetes

Dr Cigdem Ozden was confidant in her work and the vibe was on point

Rybelsus is approved for type 2 diabetes, and the Wegovy pill was approved in December 2025 for weight loss at a higher dose

In addition, some individuals find it easier to maintain healthier eating habits because cravings become more manageable

The choice between them depends on whether appetite control or direct metabolic enhancement is the priority